Thank you. It's always a pleasure to see you, and thanks for your support over the years.
Of course we see a lot of challenges and also certainly some risks, no question. I mentioned earlier some particular challenges for the three diseases. You know, there is the kind of gender dimension, and I could mention TB and the challenge of identifying people with TB. We're talking here about millions of missing cases that are not diagnosed and therefore cannot be treated. We have a number of challenges.
With regard to malaria, by the way, while we have seen significant decreases over time, we are seeing now that it's stabilizing more for a number of reasons. Climate change is beginning to make a difference here. Growing resistance to the most common diseases is a challenge for all three diseases. Yes, we have these challenges, and we have certainly, as I think you alluded to, what you might call a challenging political environment among some of the donors—